Table 1. Clinicopathological relevance analysis of LINC01225 expression in HCC patients.
LINC01225 | ||||
---|---|---|---|---|
Feather | All patients | Low expression (<median) | High expression (⩾median) | P-value |
All cases | 180 | 90 | 90 | |
Age, years | 0.871 | |||
< 60 | 125 | 63 | 62 | |
⩾ 60 | 55 | 27 | 28 | |
Gender | 0.518 | |||
Male | 155 | 76 | 79 | |
Female | 25 | 14 | 11 | |
Differentiation grade | 0.011 | |||
Well | 80 | 50 | 30 | |
Moderate | 30 | 12 | 18 | |
Poorly | 70 | 28 | 42 | |
Tumor size (cm) | 0.000 | |||
⩽ 5 | 99 | 64 | 35 | |
> 5 | 81 | 26 | 55 | |
Tumor number | 0.172 | |||
Solitary | 158 | 82 | 76 | |
Multiple | 22 | 8 | 14 | |
Tumor capsular | 0.017 | |||
Incomplete | 12 | 2 | 10 | |
Complete | 168 | 88 | 80 | |
TNM stage (I:II:III) | 0.000 | |||
I | 85 | 57 | 28 | |
II | 24 | 13 | 11 | |
III | 71 | 20 | 51 | |
Metastasis | 0.000 | |||
Yes | 58 | 11 | 47 | |
No | 122 | 79 | 43 |
Total data from 180 HCC patients were analyzed. For the expression of LINC01225, the median expression level was used as the cutoff. Data were analyzed by chi-squared test. P-value in bold indicates statistically significant.